跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Laboxtat 80 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Laboxtat 80
Approved
STANDARD
Laboxtat 80
Sunrise International Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fcda7e475db2938d
Company
Sunrise International Labs Limited
Type
Standard
Approval Details
Approval Id
fcda7e475db2938d
Drug Approval Philippines Name
Laboxtat 80
Product Name
Laboxtat 80
Registration Number
DRP-12600-02
Brand Name
Laboxtat 80
Generic Name
Febuxostat
Dosage Form
Film-Coated Tablet
Dosage Strength
80 mg
Manufacturer
Sunrise International Labs Limited
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Labmate Pharma Inc.
Issuance Date
27 October 2022
Expiry Date
14 September 2027
Pharmacologic Category
Antigout
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fcda7e475db2938d
Type
Standard
Back to Philippines FDA Approvals